Cardiac Tamponade After COVID-19 Vaccination

J Emerg Med. 2022 Feb;62(2):250-253. doi: 10.1016/j.jemermed.2021.10.008. Epub 2021 Oct 23.

Abstract

Background: Acute pericarditis is a diffuse inflammation of the pericardial sac with many well-defined etiologies. Acute pericarditis as a vaccine-related adverse event is a rare entity, and the association between pericarditis and the immunogenic response to Coronavirus disease 2019 (COVID-19) vaccines is still being fully characterized.

Case report: A previously healthy 18-year-old man presented with fever, pleuritic chest pain, and shortness of breath 3 weeks after receiving the first dose of a COVID-19 mRNA-based vaccine. The patient was found to have a large pericardial effusion with early tamponade physiology requiring pericardiocentesis. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: As COVID-19 vaccination becomes more prevalent globally, physicians should be aware of pericarditis as a rare but potentially serious adverse reaction. Although a direct causal link cannot be demonstrated, we present this case to increase awareness among emergency physicians of pericarditis as a rare, but potentially serious adverse event associated with COVID-19 vaccination.

Keywords: COVID-19 vaccine; pericarditis; vaccine-related adverse event.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • COVID-19 Vaccines
  • COVID-19*
  • Cardiac Tamponade* / etiology
  • Humans
  • Male
  • Pericarditis* / complications
  • SARS-CoV-2
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines